Expression-Based In Silico Screening of Candidate Therapeutic Compounds for Lung Adenocarcinoma

Abstract

We have used an in silico screening to identify compounds for treating lung cancer. One such compound 17-AAG demonstrated its anti-lung AC activity by inhibiting cell growth and promoting apoptosis and cell cycle arrest.